These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3847519)

  • 21. [Pharmaceutical preparation of BRL 25000].
    Jpn J Antibiot; 1985 Feb; 38(2):538-41. PubMed ID: 3847526
    [No Abstract]   [Full Text] [Related]  

  • 22. [In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
    Jpn J Antibiot; 1986 Mar; 39(3):842-52. PubMed ID: 3488425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Sato K; Fukumoto T
    Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibacterial activity for clinical isolates from pediatric patients of clavulanic acid/amoxicillin (1: 14) -outcomes of special drug use investigation on antibacterial activity (annual changes)].
    Ishida A; Hasegawa N; Okano H; Hara T; Yoshida P
    Jpn J Antibiot; 2013 Jun; 66(3):141-58. PubMed ID: 24167843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
    Weber DJ; Tolkoff-Rubin NE; Rubin RH
    Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antimicrobial activities of clavulanic acid/amoxicillin against freshly isolated clinical strains from outpatients].
    Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Dec; 48(12):1920-34. PubMed ID: 8587166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR; LeFrock JL
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
    Toyonaga Y; Sugita M; Nakamura H; Joh K; Takahashi T; Kurosu Y; Hori M
    Jpn J Antibiot; 1986 Apr; 39(4):1055-75. PubMed ID: 3761537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria].
    Savitskaia KI; Nekhorosheva AG; Skala LZ; Nasonov VN; Solodilova OE; Shanina AG; Dutova EN
    Antibiot Khimioter; 1992 Sep; 37(9):29-33. PubMed ID: 1444666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fundamental and clinical studies on aspoxicillin in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1985 Jul; 38(7):1868-81. PubMed ID: 3851860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.
    Witkowski G; Lode H; Höffken G; Koeppe P
    Eur J Clin Microbiol; 1982 Aug; 1(4):233-7. PubMed ID: 7173186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
    Schaad UB; Casey PA; Cooper DL
    Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
    Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
    Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
    Boon RJ; Beale AS; Comber KR; Pierce CV; Sutherland R
    Antimicrob Agents Chemother; 1982 Sep; 22(3):369-75. PubMed ID: 7137980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Laboratory and clinical studies on norfloxacin in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M
    Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience with intravenous Augmentin in the treatment of paediatric infections.
    Ploechl E; Huber EG
    J Int Med Res; 1986; 14(3):153-7. PubMed ID: 3636248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.